≥2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Mean Ca level/dose No. of Cases * No. of Non-cases ** Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI/SE/SD ** P between groups *** P for trend ****
9794175 Nomura 1998 prostate cancer quartile of 25 OH-D <34 ng/mL (based on controls freq) 38 34 crude (conditional logistic) OR 1.0 (Ref) 0.68
34–40 35 36 0.8 0.4–1.8
41–47 30 32 0.8 0.4–1.7
≥48 33 34 0.8 0.4–1.8
quartile of 1,25 OH-D <33 pg/mL 42 40 crude (conditional logistic) 1.0 (Ref) 0.87
33–39 32 30 1.0 0.5–2.1
40–48 28 34 0.7 0.3–1.6
≥49 34 32 1.0 0.5–2.1

Duplicate one row per exposure category or intervention group.

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: L-Q

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.